Irene Shih, MD
Internal Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 32 years
- University of California, San Francisco School of Medicine, 1994
Offices
1 location
Hospitals listed: 059546 · Mills-Peninsula Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shih’s office at (650) 325-6778 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54608 · Current
Licensed to practise in California · since 1995 · expires 2027-06-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$66,103
Medicare paid this office $66,103 for 111 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 89 | $40,171 | $156 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $7,024 | $149 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $6,672 | $97 |
| Return visit (30+ min) | 23 | $3,163 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,750 | $76 |
See all 8 services
| Long return visit (40+ min) | 89 | $40,171 | $156 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $7,024 | $149 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $6,672 | $97 |
| Return visit (30+ min) | 23 | $3,163 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,750 | $76 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | $1,182 | $28 |
| Influenza vaccine split virus, preservative free | 11 | $813 | $74 |
| Administration of influenza virus vaccine | 11 | $430 | $39 |
Who their Medicare patients are
111 Original Medicare patients in 2024. Average age 77 · Under 65 0% · 85 and older 21% · Women 65% · Health risk score 0.86. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 66% · Coronary heart disease 23% · Cancer 19% · Atrial fibrillation 18% · Chronic kidney disease 17% · Depression 17% · Diabetes 14% · COPD 12%.
The office billed $198,653, Medicare allowed $85,015 and paid $66,103; for 538 services of 27 kinds; $1,987 of it was for drugs given in the office and $64,116 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 111 | 538 | 77 | 0.86 | $198,653 | $66,103 |
| 2023 | 114 | 487 | 77 | 0.85 | $94,165 | $57,290 |
| 2022 | 110 | 494 | 78 | 0.81 | $86,451 | $58,213 |
| 2021 | 109 | 439 | 79 | 0.97 | $73,543 | $50,440 |
| 2020 | 106 | 466 | 79 | 0.90 | $56,032 | $38,994 |
| 2019 | 104 | 385 | 79 | 0.93 | $54,493 | $37,291 |
| 2018 | 92 | 435 | 78 | 0.90 | $60,243 | $41,856 |
| 2017 | 90 | 424 | 79 | 0.99 | $58,203 | $40,162 |
| 2016 | 94 | 449 | 79 | 0.97 | $60,828 | $41,934 |
| 2015 | 88 | 486 | 79 | 0.83 | $60,214 | $43,971 |
| 2014 | 93 | 455 | 79 | 0.98 | $60,318 | $41,207 |
| 2013 | 88 | 450 | 79 | 0.80 | $53,916 | $36,192 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 90 | $28,305 | $149 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $9,036 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 47 | $6,961 | $148 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $4,399 | $75 |
| Return visit (30+ min) | 21 | $2,217 | $96 |
| Advance care planning, first 30 minutes | 12 | $859 | $72 |
2022: 8 services
| Long return visit (40+ min) | 78 | $26,274 | $154 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $9,004 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 42 | $6,314 | $150 |
| Telephone medical discussion with physician, 11-20 minutes | 36 | $4,930 | $91 |
| Return visit (30+ min) | 24 | $3,268 | $109 |
| Advance care planning, first 30 minutes | 15 | $1,179 | $74 |
| Influenza vaccine split virus, preservative free | 17 | $1,165 | $69 |
| Administration of influenza virus vaccine | 18 | $670 | $37 |
2021: 11 services
| Long return visit (40+ min) | 75 | $24,105 | $159 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,666 | $153 |
| Return visit (30+ min) | 33 | $5,022 | $107 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $4,905 | $123 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $2,463 | $85 |
| Pneumococcal vaccine, 23-valent | 11 | $1,385 | $126 |
| Short return visit (20+ min) | 15 | $1,377 | $86 |
| Influenza vaccine split virus, preservative free | 15 | $979 | $65 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $498 | $29 |
| Administration of influenza virus vaccine | 14 | $303 | $22 |
| Administration of pneumococcal vaccine | 11 | $238 | $22 |
2020: 8 services
| Long return visit (40+ min) | 65 | $12,304 | $128 |
| Return visit (30+ min) | 52 | $9,395 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,850 | $135 |
| Short return visit (20+ min) | 29 | $2,578 | $66 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 22 | $2,272 | $73 |
| Influenza vaccine split virus, preservative free | 37 | $2,256 | $61 |
| Advance care planning, first 30 minutes | 12 | $1,328 | $78 |
| Administration of influenza virus vaccine | 40 | $878 | $21 |
2019: 6 services
| Long return visit (40+ min) | 90 | $19,551 | $122 |
| Return visit (30+ min) | 46 | $6,360 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,285 | $132 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 29 | $1,587 | $55 |
| Advance care planning, first 30 minutes | 11 | $885 | $80 |
| Administration of influenza virus vaccine | 29 | $595 | $21 |
2018: 6 services
| Long return visit (40+ min) | 81 | $19,941 | $122 |
| Return visit (30+ min) | 49 | $6,441 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $5,734 | $133 |
| Advance care planning, first 30 minutes | 27 | $2,624 | $82 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 31 | $1,621 | $52 |
| Administration of influenza virus vaccine | 32 | $875 | $26 |
2017: 7 services
| Long return visit (40+ min) | 73 | $22,293 | $125 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $4,606 | $132 |
| Return visit (30+ min) | 35 | $4,024 | $80 |
| Advance care planning, first 30 minutes | 22 | $2,174 | $70 |
| Influenza vaccine split virus, preservative free | 27 | $1,375 | $47 |
| Administration of influenza virus vaccine | 27 | $868 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $187 | $16 |
2016: 8 services
| Long return visit (40+ min) | 80 | $21,940 | $123 |
| Return visit (30+ min) | 44 | $7,326 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $5,231 | $131 |
| Advance care planning, first 30 minutes | 16 | $1,247 | $78 |
| Influenza vaccine split virus, preservative free | 27 | $1,124 | $42 |
| Short return visit (20+ min) | 14 | $997 | $52 |
| Administration of influenza virus vaccine | 28 | $838 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $247 | $15 |
2015: 7 services
| Long return visit (40+ min) | 73 | $17,717 | $121 |
| Pneumococcal vaccine, 13-valent | 54 | $8,148 | $151 |
| Return visit (30+ min) | 49 | $7,166 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,071 | $131 |
| Administration of pneumococcal vaccine | 54 | $1,616 | $30 |
| Influenza vaccine split virus, preservative free | 29 | $1,097 | $35 |
| Administration of influenza virus vaccine | 30 | $957 | $30 |
2014: 8 services
| Long return visit (40+ min) | 80 | $21,767 | $118 |
| Return visit (30+ min) | 46 | $6,586 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,610 | $128 |
| Extended office or other outpatient service, first hour | 14 | $1,538 | $85 |
| Short return visit (20+ min) | 14 | $971 | $61 |
| Influenza vaccine split virus, preservative free | 25 | $849 | $33 |
| Administration of influenza virus vaccine | 27 | $838 | $30 |
| Administration of pneumococcal vaccine | 17 | $509 | $30 |
2013: 6 services
| Long return visit (40+ min) | 68 | $15,189 | $116 |
| Return visit (30+ min) | 56 | $10,365 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $3,935 | $127 |
| Short return visit (20+ min) | 22 | $1,944 | $59 |
| Administration of influenza virus vaccine | 35 | $1,048 | $30 |
| Influenza vaccine split virus, preservative free | 31 | $966 | $31 |
Drugs they prescribed that Part D paid
$136,711
Pharmacies billed $136,711 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 1,341) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,184 generic and fewer than 11 brand-name prescriptions · $136,711 in drug cost · 43 antibiotic prescriptions to 28 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 16 | $16,211 | $1,013 |
| Breo Ellipta | 13 | $5,765 | $443 |
| Rivastigmine | 13 | $3,295 | $253 |
| Yuvafem | 16 | $2,567 | $160 |
| Synthroid | 14 | $2,364 | $169 |
See all 36 drugs
| Ozempic | 16 | $16,211 | $1,013 |
| Breo Ellipta | 13 | $5,765 | $443 |
| Rivastigmine | 13 | $3,295 | $253 |
| Yuvafem | 16 | $2,567 | $160 |
| Synthroid | 14 | $2,364 | $169 |
| Estradiol | 16 | $1,429 | $89 |
| Potassium Chloride | 17 | $1,401 | $82 |
| Rosuvastatin | 96 | $1,126 | $12 |
| Lorazepam | 39 | $864 | $22 |
| Mirtazapine | 17 | $857 | $50 |
| Quetiapine | 15 | $724 | $48 |
| Amlodipine Besylate | 88 | $669 | $8 |
| Tamsulosin | 32 | $636 | $20 |
| Benazepril | 24 | $510 | $21 |
| Atorvastatin | 60 | $503 | $8 |
| Duloxetine | 15 | $481 | $32 |
| Albuterol Sulfate Hfa | 13 | $443 | $34 |
| Trazodone | 28 | $411 | $15 |
| Diltiazem 24hr Er (Cd) | 11 | $395 | $36 |
| Gabapentin | 15 | $388 | $26 |
| Metoprolol | 18 | $381 | $21 |
| Lisinopril | 63 | $379 | $6 |
| Irbesartan | 11 | $333 | $30 |
| Levothyroxine | 29 | $322 | $11 |
| Pantoprazole | 25 | $310 | $12 |
| Pregabalin | 13 | $306 | $24 |
| Zolpidem | 37 | $273 | $7 |
| Fluticasone Propionate | 11 | $189 | $17 |
| Montelukast | 19 | $186 | $10 |
| Omeprazole | 11 | $167 | $15 |
| Escitalopram | 13 | $152 | $12 |
| Losartan | 24 | $141 | $6 |
| Pravastatin | 12 | $93 | $8 |
| Carvedilol | 11 | $91 | $8 |
| Furosemide | 14 | $63 | $4 |
| Metformin | 23 | $40 | $2 |
Year by year
| 2024 | 1,341 | 127 | 1% (15) | None | $136,711 |
| 2023 | 1,198 | 126 | None | 9% | $86,996 |
| 2022 | 1,022 | 117 | 1% (11) | None | $88,962 |
| 2021 | 924 | 87 | 1% (11) | 9% | $65,942 |
| 2020 | 913 | 80 | 1% (12) | 10% | $68,555 |
| 2019 | 982 | 88 | 2% (18) | None | $67,594 |
| 2018 | 927 | 82 | 3% (25) | 13% | $73,016 |
| 2017 | 963 | 78 | 1% (12) | 17% | $79,840 |
| 2016 | 985 | 76 | None | None | $73,050 |
| 2015 | 1,150 | 78 | 2% (28) | 27% | $85,564 |
| 2014 | 1,301 | 76 | 3% (37) | None | $106,865 |
| 2013 | 1,226 | 77 | 2% (29) | None | $75,100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Breo Ellipta | 11 | $4,586 | $417 |
| Arnuity Ellipta | 11 | $3,321 | $302 |
| Rivastigmine | 11 | $2,798 | $254 |
| Synthroid | 13 | $2,689 | $207 |
| Estradiol | 17 | $2,109 | $124 |
| Rosuvastatin | 69 | $1,042 | $15 |
| Tamsulosin | 19 | $987 | $52 |
| Celecoxib | 11 | $628 | $57 |
| Lorazepam | 44 | $607 | $14 |
| Mometasone Furoate | 13 | $534 | $41 |
| Trazodone | 23 | $514 | $22 |
| Amlodipine Besylate | 64 | $510 | $8 |
| Duloxetine | 11 | $498 | $45 |
| Mirtazapine | 11 | $493 | $45 |
| Atorvastatin | 63 | $456 | $7 |
| Losartan | 27 | $370 | $14 |
| Benazepril | 18 | $364 | $20 |
| Levothyroxine | 32 | $355 | $11 |
| Zolpidem | 38 | $343 | $9 |
| Pregabalin | 14 | $341 | $24 |
| Irbesartan | 11 | $334 | $30 |
| Pantoprazole | 20 | $332 | $17 |
| Lisinopril | 56 | $330 | $6 |
| Ipratropium | 22 | $318 | $14 |
| Pravastatin | 20 | $279 | $14 |
| Buspirone | 17 | $201 | $12 |
| Azithromycin | 11 | $140 | $13 |
| Metformin | 27 | $132 | $5 |
| Escitalopram | 11 | $131 | $12 |
| Montelukast | 23 | $119 | $5 |
| Prednisone | 13 | $66 | $5 |
| Carvedilol | 12 | $47 | $4 |
2022: 30 drugs
| Eliquis | 14 | $10,159 | $726 |
| Arnuity Ellipta | 15 | $6,471 | $431 |
| Synthroid | 13 | $2,677 | $206 |
| Estradiol | 18 | $2,535 | $141 |
| Rosuvastatin | 63 | $1,609 | $26 |
| Duloxetine | 13 | $1,441 | $111 |
| Amlodipine Besylate | 49 | $932 | $19 |
| Diltiazem 24hr Er (Cd) | 11 | $700 | $64 |
| Atorvastatin | 67 | $670 | $10 |
| Celecoxib | 12 | $594 | $50 |
| Ipratropium | 12 | $567 | $47 |
| Mometasone Furoate | 12 | $509 | $42 |
| Paroxetine | 14 | $437 | $31 |
| Lorazepam | 31 | $435 | $14 |
| Levothyroxine | 26 | $391 | $15 |
| Trazodone | 12 | $354 | $29 |
| Tamsulosin | 12 | $330 | $27 |
| Losartan | 24 | $321 | $13 |
| Benazepril | 18 | $312 | $17 |
| Lisinopril | 51 | $308 | $6 |
| Metoprolol | 11 | $290 | $26 |
| Pravastatin | 16 | $277 | $17 |
| Carvedilol | 15 | $265 | $18 |
| Nabumetone | 11 | $228 | $21 |
| Zolpidem | 23 | $186 | $8 |
| Montelukast | 11 | $137 | $12 |
| Hydrochlorothiazide | 11 | $114 | $10 |
| Metformin | 24 | $100 | $4 |
| Escitalopram | 15 | $97 | $6 |
| Alendronate | 13 | $88 | $7 |
2021: 27 drugs
| Synthroid | 20 | $2,624 | $131 |
| Esomeprazole Magnesium | 12 | $2,208 | $184 |
| Atorvastatin | 85 | $1,455 | $17 |
| Bupropion Xl | 15 | $1,299 | $87 |
| Silodosin | 14 | $1,056 | $75 |
| Amlodipine Besylate | 47 | $929 | $20 |
| Duloxetine | 22 | $871 | $40 |
| Losartan | 31 | $552 | $18 |
| Paroxetine | 15 | $541 | $36 |
| Mometasone Furoate | 11 | $492 | $45 |
| Pravastatin | 19 | $465 | $24 |
| Levothyroxine | 23 | $461 | $20 |
| Carvedilol | 25 | $421 | $17 |
| Rosuvastatin | 13 | $406 | $31 |
| Fluticasone Propionate | 17 | $404 | $24 |
| Trazodone | 12 | $326 | $27 |
| Tamsulosin | 17 | $322 | $19 |
| Lisinopril | 40 | $272 | $7 |
| Zolpidem | 20 | $237 | $12 |
| Sertraline | 15 | $226 | $15 |
| Montelukast | 12 | $212 | $18 |
| Benazepril | 12 | $207 | $17 |
| Lorazepam | 12 | $182 | $15 |
| Nabumetone | 11 | $156 | $14 |
| Citalopram Hbr | 13 | $122 | $9 |
| Alendronate | 13 | $89 | $7 |
| Metformin | 18 | $43 | $2 |
2020: 30 drugs
| Eliquis | 21 | $19,112 | $910 |
| Estradiol | 15 | $2,398 | $160 |
| Esomeprazole Magnesium | 13 | $2,288 | $176 |
| Synthroid | 20 | $2,112 | $106 |
| Silodosin | 14 | $1,827 | $131 |
| Atorvastatin | 74 | $1,287 | $17 |
| Amlodipine Besylate | 52 | $888 | $17 |
| Celecoxib | 15 | $856 | $57 |
| Ipratropium | 15 | $837 | $56 |
| Pregabalin | 14 | $815 | $58 |
| Bupropion Xl | 17 | $800 | $47 |
| Duloxetine | 18 | $734 | $41 |
| Trazodone | 18 | $631 | $35 |
| Paroxetine | 15 | $590 | $39 |
| Losartan | 37 | $442 | $12 |
| Levothyroxine | 18 | $423 | $24 |
| Pravastatin | 16 | $423 | $26 |
| Fluticasone Propionate | 16 | $421 | $26 |
| Sertraline | 24 | $407 | $17 |
| Tamsulosin | 15 | $396 | $26 |
| Lisinopril | 41 | $394 | $10 |
| Omeprazole | 12 | $287 | $24 |
| Lorazepam | 15 | $284 | $19 |
| Carvedilol | 18 | $272 | $15 |
| Zolpidem | 24 | $175 | $7 |
| Spironolactone | 12 | $106 | $9 |
| Alendronate | 14 | $98 | $7 |
| Metformin | 19 | $77 | $4 |
| Simvastatin | 13 | $50 | $4 |
| Citalopram Hbr | 12 | $44 | $4 |
2019: 32 drugs
| Trulicity | 12 | $9,758 | $813 |
| Celecoxib | 26 | $2,482 | $95 |
| Synthroid | 28 | $2,183 | $78 |
| Silodosin | 11 | $1,656 | $151 |
| Atorvastatin | 94 | $1,548 | $16 |
| Duloxetine | 14 | $1,066 | $76 |
| Tamsulosin | 18 | $837 | $47 |
| Potassium Citrate Er | 11 | $816 | $74 |
| Bupropion Xl | 15 | $746 | $50 |
| Amlodipine Besylate | 50 | $632 | $13 |
| Metoprolol | 15 | $614 | $41 |
| Paroxetine | 14 | $576 | $41 |
| Chlorthalidone | 11 | $566 | $51 |
| Trazodone | 20 | $545 | $27 |
| Losartan | 42 | $532 | $13 |
| Finasteride | 15 | $394 | $26 |
| Montelukast | 11 | $389 | $35 |
| Pravastatin | 12 | $385 | $32 |
| Carvedilol | 22 | $352 | $16 |
| Lisinopril | 33 | $314 | $10 |
| Fluticasone Propionate | 11 | $284 | $26 |
| Lorazepam | 15 | $280 | $19 |
| Sertraline | 23 | $247 | $11 |
| Zolpidem | 31 | $213 | $7 |
| Omeprazole | 14 | $208 | $15 |
| Hydrochlorothiazide | 11 | $153 | $14 |
| Pantoprazole | 14 | $152 | $11 |
| Diazepam | 14 | $105 | $8 |
| Alendronate | 13 | $101 | $8 |
| Amoxicillin | 11 | $74 | $7 |
| Metformin | 15 | $70 | $5 |
| Citalopram Hbr | 12 | $50 | $4 |
2018: 19 drugs
| Celecoxib | 37 | $2,944 | $80 |
| Synthroid | 30 | $2,314 | $77 |
| Atorvastatin | 115 | $1,845 | $16 |
| Metoprolol | 31 | $817 | $26 |
| Amlodipine Besylate | 45 | $689 | $15 |
| Potassium Citrate Er | 13 | $626 | $48 |
| Chlorthalidone | 13 | $568 | $44 |
| Tamsulosin | 17 | $565 | $33 |
| Losartan | 37 | $551 | $15 |
| Zolpidem | 35 | $302 | $9 |
| Lorazepam | 15 | $273 | $18 |
| Omeprazole | 19 | $259 | $14 |
| Trazodone | 12 | $179 | $15 |
| Sertraline | 11 | $157 | $14 |
| Benazepril | 19 | $140 | $7 |
| Lisinopril | 17 | $117 | $7 |
| Atenolol | 23 | $85 | $4 |
| Metformin | 17 | $68 | $4 |
| Simvastatin | 16 | $24 | $1 |
2017: 26 drugs
| Nicotrol Ns | 12 | $18,656 | $1,555 |
| Aggrenox | 11 | $5,526 | $502 |
| Advair Diskus | 12 | $3,928 | $327 |
| Celecoxib | 28 | $3,567 | $127 |
| Duloxetine | 19 | $3,320 | $175 |
| Synthroid | 43 | $1,984 | $46 |
| Atorvastatin | 94 | $1,420 | $15 |
| Amlodipine Besylate | 62 | $763 | $12 |
| Pravastatin | 26 | $612 | $24 |
| Metoprolol | 33 | $604 | $18 |
| Losartan | 30 | $486 | $16 |
| Lorazepam | 26 | $484 | $19 |
| Trazodone | 21 | $423 | $20 |
| Zolpidem | 35 | $399 | $11 |
| Paroxetine | 15 | $372 | $25 |
| Phenytoin Sodium Extended | 11 | $356 | $32 |
| Omeprazole | 12 | $251 | $21 |
| Alprazolam | 14 | $233 | $17 |
| Mirtazapine | 17 | $231 | $14 |
| Benazepril | 25 | $165 | $7 |
| Hydrochlorothiazide | 13 | $147 | $11 |
| Lisinopril | 21 | $139 | $7 |
| Sertraline | 12 | $92 | $8 |
| Atenolol | 16 | $64 | $4 |
| Simvastatin | 22 | $54 | $2 |
| Citalopram Hbr | 12 | $21 | $2 |
2016: 24 drugs
| Nicotrol Ns | 12 | $15,839 | $1,320 |
| Spiriva | 14 | $5,465 | $390 |
| Duloxetine | 20 | $3,207 | $160 |
| Synthroid | 42 | $1,861 | $44 |
| Atorvastatin | 65 | $1,101 | $17 |
| Amlodipine Besylate | 73 | $781 | $11 |
| Metoprolol | 30 | $711 | $24 |
| Zolpidem | 49 | $616 | $13 |
| Lorazepam | 25 | $612 | $24 |
| Pravastatin | 28 | $574 | $21 |
| Omeprazole | 35 | $531 | $15 |
| Losartan | 38 | $504 | $13 |
| Trazodone | 30 | $444 | $15 |
| Escitalopram | 16 | $314 | $20 |
| Levothyroxine | 11 | $305 | $28 |
| Alprazolam | 15 | $217 | $14 |
| Fluticasone Propionate | 13 | $182 | $14 |
| Benazepril | 34 | $176 | $5 |
| Prednisone | 13 | $155 | $12 |
| Sertraline | 17 | $148 | $9 |
| Lisinopril | 18 | $105 | $6 |
| Simvastatin | 29 | $93 | $3 |
| Carvedilol | 13 | $92 | $7 |
| Citalopram Hbr | 16 | $47 | $3 |
2015: 36 drugs
| Nicotrol Ns | 12 | $13,190 | $1,099 |
| Spiriva | 22 | $6,899 | $314 |
| Namenda | 15 | $5,707 | $380 |
| Crestor | 17 | $4,039 | $238 |
| Benicar | 12 | $2,725 | $227 |
| Duloxetine | 28 | $2,563 | $92 |
| Celecoxib | 14 | $2,512 | $179 |
| Synthroid | 46 | $1,870 | $41 |
| Tolterodine | 11 | $1,502 | $137 |
| Sulfamethoxazole-Trimethoprim | 11 | $1,256 | $114 |
| Metoprolol | 29 | $818 | $28 |
| Atorvastatin | 55 | $768 | $14 |
| Pravastatin | 29 | $607 | $21 |
| Lorazepam | 35 | $561 | $16 |
| Omeprazole | 35 | $471 | $13 |
| Amlodipine Besylate | 65 | $468 | $7 |
| Levothyroxine | 29 | $465 | $16 |
| Piroxicam | 12 | $442 | $37 |
| Phenytoin Sodium Extended | 16 | $406 | $25 |
| Tamsulosin | 14 | $403 | $29 |
| Zolpidem | 36 | $366 | $10 |
| Losartan | 39 | $271 | $7 |
| Potassium Chloride | 14 | $255 | $18 |
| Clopidogrel | 19 | $223 | $12 |
| Hydrochlorothiazide | 18 | $208 | $12 |
| Enalapril Maleate | 11 | $190 | $17 |
| Alprazolam | 11 | $179 | $16 |
| Fluticasone Propionate | 13 | $171 | $13 |
| Benazepril | 38 | $152 | $4 |
| Lisinopril | 19 | $130 | $7 |
| Cyclobenzaprine | 11 | $111 | $10 |
| Simvastatin | 27 | $97 | $4 |
| Escitalopram | 12 | $87 | $7 |
| Atenolol | 17 | $85 | $5 |
| Carvedilol | 12 | $50 | $4 |
| Amoxicillin | 11 | $30 | $3 |
2014: 39 drugs
| Nicotrol Ns | 12 | $11,734 | $978 |
| Celebrex | 17 | $8,996 | $529 |
| Crestor | 27 | $7,226 | $268 |
| Morphine Sulfate Er | 11 | $5,471 | $497 |
| Spiriva | 18 | $5,235 | $291 |
| Duloxetine | 27 | $4,794 | $178 |
| Cymbalta | 18 | $4,318 | $240 |
| Dexilant | 17 | $4,095 | $241 |
| Rapaflo | 16 | $3,950 | $247 |
| Nasonex | 13 | $3,219 | $248 |
| Bystolic | 17 | $2,404 | $141 |
| Synthroid | 55 | $1,816 | $33 |
| Atorvastatin | 63 | $978 | $16 |
| Amlodipine Besylate | 76 | $732 | $10 |
| Azelastine | 12 | $668 | $56 |
| Metoprolol | 23 | $662 | $29 |
| Omeprazole | 40 | $536 | $13 |
| Levothyroxine | 41 | $472 | $12 |
| Pravastatin | 24 | $426 | $18 |
| Zolpidem | 37 | $375 | $10 |
| Spironolactone | 24 | $341 | $14 |
| Lisinopril | 39 | $323 | $8 |
| Losartan | 45 | $319 | $7 |
| Phenytoin Sodium Extended | 16 | $311 | $19 |
| Piroxicam | 13 | $279 | $21 |
| Ipratropium | 14 | $275 | $20 |
| Lorazepam | 19 | $265 | $14 |
| Benazepril | 38 | $254 | $7 |
| Hydrochlorothiazide | 14 | $223 | $16 |
| Simvastatin | 24 | $182 | $8 |
| Clopidogrel | 14 | $182 | $13 |
| Fluticasone Propionate | 13 | $151 | $12 |
| Carvedilol | 17 | $140 | $8 |
| Prednisone | 17 | $118 | $7 |
| Trazodone | 12 | $115 | $10 |
| Atenolol | 16 | $94 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $84 | $7 |
| Enalapril Maleate | 12 | $80 | $7 |
| Furosemide | 13 | $44 | $3 |
2013: 35 drugs
| Cymbalta | 49 | $11,761 | $240 |
| Celebrex | 22 | $7,338 | $334 |
| Crestor | 25 | $6,187 | $247 |
| Benicar | 27 | $4,337 | $161 |
| Rapaflo | 18 | $3,814 | $212 |
| Dexilant | 23 | $3,648 | $159 |
| Diovan | 19 | $2,355 | $124 |
| Evista | 11 | $1,984 | $180 |
| Atorvastatin | 46 | $1,505 | $33 |
| Metoprolol | 45 | $1,140 | $25 |
| Synthroid | 42 | $1,040 | $25 |
| Piroxicam | 13 | $748 | $58 |
| Amlodipine Besylate | 67 | $574 | $9 |
| Omeprazole | 31 | $554 | $18 |
| Hydrocodone-Acetaminophen | 14 | $419 | $30 |
| Potassium Chloride | 19 | $388 | $20 |
| Levothyroxine | 38 | $340 | $9 |
| Lisinopril | 47 | $324 | $7 |
| Lorazepam | 26 | $322 | $12 |
| Pantoprazole | 22 | $306 | $14 |
| Losartan | 24 | $295 | $12 |
| Pravastatin | 16 | $277 | $17 |
| Simvastatin | 29 | $270 | $9 |
| Zolpidem | 36 | $250 | $7 |
| Carvedilol | 15 | $193 | $13 |
| Phenytoin Sodium Extended | 11 | $189 | $17 |
| Benazepril | 23 | $186 | $8 |
| Sertraline | 13 | $166 | $13 |
| Trazodone | 24 | $156 | $6 |
| Prednisone | 13 | $133 | $10 |
| Losartan-Hydrochlorothiazide | 12 | $112 | $9 |
| Diltiazem 24hr Er | 11 | $106 | $10 |
| Triamterene-Hctz | 11 | $101 | $9 |
| Enalapril Maleate | 13 | $57 | $4 |
| Atenolol | 12 | $52 | $4 |
Professional record
- NPI
- 1982773966
- Licence
- CA A54608California A54608: Current · expires 2027-06-30
- Trained
- University of California, San Francisco School of Medicine, 1994 · 32 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 211 Quarry Rd, Ste 203 Mc5993, Palo Alto, CA, 94304
- NPI first listed
- 2006-11-06
- NPI last updated
- 2013-03-27
This is when the NPI record was last certified, not a medical board exam.